Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma

• Main Authors: Li J (Author), Jia Y (Author), Shao C (Author), Li Y (Author), Song J (Author)
• Format: Book
• Published: Dove Medical Press, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Jinpeng Li,1,* Yuntao Jia,1,* Changdong Shao,2,* Yuanming Li,3 Jinlong Song1 1Intervention Ward 1, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China; 2Qixia Hosp...